STOCKHOLM, Feb. 3, 2021 /PRNewswire/ -- WITH-Global is a
distribution mainly active in the field of diagnostic imaging and
radiation therapy. With a team of 27 employees WITH-Global has a
strong focus on providing services to its customers reaching from
consulting to maintenance and hospital network services.
WITH-Global has obtained the distribution rights for C-RAD's
positioning products and the HIT Laser systems.
Mr Joo Il Dong, Managing Director of WITH-Global comments, `'We
are very excited to team up with C-RAD and to provide surface
tracking to the Korean market. This will further grow our support
in the Radiation Oncology community for Korea."
`'WITH-Global's extensive healthcare network will provide C-RAD
a strong presence for existing customers and new customers in
Korea. The ability to provide strong clinical support in Korea
alongside the WITH-Global team will be instrumental to the ongoing
success.'' says James Nguyen APAC Sales Director of C-RAD
C-RAD has multiple installations of its Catalyst and Sentinel
products at leading cancer centers in South Korea. The South Korean market has
approximately 70 radiation therapy centers and is one of the most
developed healthcare markets in Asia.
"I am very pleased to announce the partnership with WITH-Global.
We were looking for a partner, that has a strong sales
organization, in combination with a clinical support team to
provide excellent service to existing and future customers." says
Tim Thurn, CEO and President of
C-RAD AB, "Motion Management is on its way to become standard of
care for advanced radiation therapy. The cutting-edge C-RAD
solution provides the tools needed to support high precision
treatments in an save and efficient radiation therapy
Established in 2014, WITH Global leads and provides
Diagnostic Imaging Equipment, Hospital Networking Systems alongside
the Consulting and Maintenance Program to capital equipment. The
philosophy of honesty and beyond satisfaction has led to strong
relationships in the healthcare arena from Diagnostic Imaging and
C-RAD develops surface-guided imaging solutions for radiation
therapy to allow highly accurate dose delivery to the tumor, and at
the same time, to protect healthy tissue from unwanted exposure.
Using high-speed 3D cameras combined with augmented reality, C-RAD
supports the initial patient setup process and monitors the
patient's motion during treatment to ensure high confidence, an
efficient workflow, and improved accuracy. C-RAD monitors the
patient's motion without the use of tattoos or additional imaging
dose, to deliver the highest level of patient safety and
C-RAD. Inspiring excellence in cancer treatment.
C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit
For further information:
Tim Thurn, CEO C-RAD AB, Phone
+46-18-666930, Email email@example.com
This information was brought to you by Cision
The following files are available for download: